Stuart Nancy's most recent trade in KalVista Pharmaceuticals Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KalVista Pharma Inc | Nancy Stuart | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Jun 2026 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | |
| KalVista Pharma Inc | Nancy Stuart | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Jun 2026 | 14,000 | 0 | - | - | Stock Option (Right to Buy) | |
| KalVista Pharma Inc | Nancy Stuart | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Jun 2026 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| KalVista Pharma Inc | Nancy Stuart | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Jun 2026 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| KalVista Pharma Inc | Nancy Stuart | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Jun 2026 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| KalVista Pharma Inc | Stuart Nancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| KalVista Pharma Inc | Nancy Stuart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| KalVista Pharma Inc | Nancy Stuart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2022 | 10,000 | 10,000 | - | - | Employee Stock Option (right to buy) |